Intraceilular pathways leading from membrane receptor engagement to apoptotic cell death are still poorly characterized. We investigated the intracellular signaling generated after cross-linking of CD95 (Fas/Apo-1 antigen), a broadly expressed ceil surface receptor whose engagement results in triggering of cellular apoptotic programs. DX2, a new functional anti-CD95 monodonal antibody was produced by immunizing mice with human CD95-transfected L ceils. Crosslinkiug of CD95 with DX2 resulted in the activation of a sphingomydinase (SMase) in promydocytic U937 ceils, as well as in other human tumor ceil lines and in CD95-transfected murine cells, as demonstrated by induction of in vivo sphingomydin (SM) hydrolysis and generation of ceramide. Direct in vitro measurement of enzymatic activity within CD95-stimulated U937 cell extracts, using labded SM vesicles as substrates, showed strong SMase activity, which required pH 5.0 for optimal substrate hy&olysis. Finally, all CD95-sensitive cell lines tested could be induced to undergo apoptosis after exposure to ceil-permeant C2-ceramide. These data indicate that CD95 cross-linking induces SM breakdown and ceramide production through an acidic SMase, thus providing the first information regarding early signal generation from CD95, and may be rdevant in defining the biochemical nature of intraceilular messengers leading to apoptotic cell death.
T he CD95 (Fas/Apo-1 antigen) is an *45-kD single transmembrane receptor expressed on a variety of normal and neoplastic cells (1, 2) . It has been suggested that CD95 may play a fundamental role in regulation of tissue development and homeostasis, since its molecular eross-linking results in apoptotic cell death (3, 4) . In lymphoid cells, CD95 is preferentially induced on the ceLl surface after cellular activation (5) and its expression might be crucial to allow clonal selection by cell ddetion in the thymus, as well as suicide of antoreactive clones in the periphery. This is strongly suggested by the evidence that the autoimmune disease prone lpr mouse carries a mutation in the murine CD95 gene (6) . Primary sequence analysis of the extraceUular portion of CD95 has revealed strong homologies with the extraceLlular domain of receptors belonging to the TNF receptor family, which indudes TNF receptor types 1 and 2 (TNFR1/2), the low affinity nerve growth factor receptor, and lymphocyte receptors such as CD27, CD30, CD40, and OX40 (1, 2) . An integral membrane protein, with strong homology to TNF-ot and -~, has been recently identified as a Fas ligand (7) . Moreover, a moderate degree of homology (26% identity in a stretch of 65 amino acids [aa] ) between the intracdlular portion of the human CD95 and the 55-kD TNFR1, has been observed. Mutational analysis of this domain has revealed its involvement in the generation of the apoptotic signal from both CD95 and TNFR1 (8, 9) . These data suggested that common effectors may transduce the apoptotic signal from both receptors.
Whereas no information is available about the biochemical nature of the signals generated via CD95, signaling through TNFR1 has been extensivdy characterized. Its 221-aa intracellular portion has been shown to be functionally coupled with different phospholipases, including phospholipase A2 (PLA2) 1 (10), phosphatidylcholine-specific phospholipase C (PC-PI, C) (11), and sphingomydinase (SMase) (12, 14) . A specific role for the SMase pathway, and in particular for ceramide, produced from sphingomydin (SM) hydrolysis, in 1 Abbreviations used in this paper: PC-PLC, phosphatidylcholin~specific phospholipase C; PLA2, phospholipase A2; SM, sphingomydin; SMase, sphingomydinase.
the generation of the apoptotic signal has been recently suggested by the demonstration that synthetic cell-permeant ceramides can directly promote apoptosis (15) , by inducing double-stranded DNA fragmentation (16) . We therefore investigated whether SM hydrolysis and ceramide production could be induced by CD95. Our data indicate that crosslinking of the CD95 receptor triggers SM breakdown in U937 promydocytic cells, as well as in other tumor cell lines, through an acidic SMase.
Material, and Methods
Generation ofAnti-CD95 mAbs. Human Fas cDNA was generated by P,T-PCR. (17) from the Jurkat cell line and was subsequently subdoned into pBJ. Primers used to generate a full-length Fas cDNA were: sense, GGG CTC GAG ACA ACC ATG CTG GC~ ATC TGG (including an XhoI cloning site); anti-sense, GGG GAT ATC TTC ACT CTA GAC CAA GCT TTG (containing an EcoRV cloning site). Murine L cells were cotransfected with 15 #g human Fas-pBJ plasmid using 100/~g lipofectin (GIBCO BRL, Gaithersburg, MD) and CA18-resistant cells were selected, as described previously (18) . Anti-CD95 hybridomas DX2 (IgG1) was generated by immunizing C3H/He mice with CD95 transfected L cells and fusing immune splenocytes with Sp2/0 myeloma cells.
Cell Lines. The human T cell lymphoma HUT78, human T cell leukemia Jurkat, and human promydocytic leukemia U937 cell lines were grown in R.PMI supplemented with 10% FCS, 1 mM glutamine, and antibiotics (complete medium). The routine lymphocytic leukemia L1210 cell line was transfected with human CD95 (Fas-pBJ plasmid) and G418 selected, as described previously (18) . The resulting L1210-Fas cell line, stably expressing human CD95, was grown in complete medium.
DNA Labeling and Flow Cytometry Analysis. Cells at 5 x 10S/m1 in complete medium were incubated in 24-weU cell culture plates (Costar Corp., Cambridge, M_A) coated with saturating amounts of DX2 antibody. In different experiments, cells were treated with 50 #M C2-ceramide (N-acetyl-n-sphingosine; Sigma Chemical Co., St. Louis, MO) or C2-dihydroceramide (N-acetyln-dihydrosphingosine; Biomol, Plymouth Meeting, PA). After different times of incubation, cells were recovered and washed in PBS and processed for apoptotic cell detection (19) . Briefly, the cell pellet was gently resuspended in 1 ml hypotonic fluorochrome solution (50/~g/ml propidium iodide in 0.1% sodium citrate plus 0.1% Triton X-100, Sigma Chemical Co.) in 12 x 75 polystyrene tubes and kept overnight at 4~ in the dark until flow cytometry analysis. The propidium iodide fluorescence emission of individual nuclei was filtered through a 585/42-nm band pass filter and measured on a logarithmic scale by a FACScan | cytometer (Becton Dickinson & Co., Mountain View, CA). Cell debris were exduded from analysis by appropriately gating on physical parameters. The number of apoptotic cells was determined by evaluating the percentage of hypodiploid nuclei (20) .
SMase assay. Cells were labeled for 48 h with [N-methyl-14C]choline (1 #Ci/ml, sp act 56.4 mCi/mmol) and then serum starved for 4 h in medium supplemented with 2% BSA (14) . Aliquots of 107 cells were suspended in 1 ml PBS and treated for the indicated times with control mAb or with DX2 mAb (1/~g/ml), cross-linked by goat anti-mouse Ig (1 #g/ml), or with recombinant TNF-o~ (Genzyme Corp., Cambridge, MA) (100 ng/ml). Stimulation was stopped by immersion of samples in methanol/dry ice (-70~ for 10 s followed by centrifugation at 4~ in a microfuge. Cell pellets were resuspended in ice-cold CH3OH/CHC13/H20 (2.5:1.25:1). Phospholipids were extracted, dried under nitrogen, resuspended in 200/~1 chloroform, and applied to a Silica Gel TLC plate (Merck, Darmstadt, Germany), with an automatic applicator (Linomat IV; Camag, Muttenz, Switzerland). Samples containing equal amounts of radioactivity were loaded. The amount of labeled PC, which remained constant when labeled at equilibrium, was used as internal control to normalize for equal amounts of loaded material. Phospholipids were separated by TIC using a solvent system containing CHC13/CH~OH/CH3COOH/H20 (100:60: 20:5). LysoPC, PC, and bovine brain SM (Sigma Chemical Co.) were used as standards and visualized in iodine vapor. The radioactive spots were visualized by autoradiography, scraped from the plate, and counted by liquid scintillation. SMase activity was expressed as pmohs of SM hydrolyzed/106 cells.
For in vitro SMase assay, the cells were treated with DX2 mAb (1/~g/ml) cross-linked by goat anti-mouse Ig (1 #g/ml) or with TNF-c~ (100 ng/ml) at 37~ for the indicated times, washed, and then resuspended in Tris buffer, pH 7.4, or sodium acetate buffer, pH 5.0, containing 10 mM PMSF, 100 mM bacitracin, I mM benzamidine, 1 mM aprotinin, 1 mg/ml leupeptin, 1 mg/ml pepstatin, and 5 mg/ml soybean trypsin inhibitor (Sigma Chemical Co.). Cells were lysed by sonication with a cell sonifier (Vibracell, Sonic & Materials Inc., Danbury, CT). Protein concentrations were determined using a protein assay (Bio-Rad Laboratories, Richmond, CA). 100 #g of the whole cell lysate was added to 250 #1 reaction buffer containing the substrate [N-methyl-l~C]SM (0.2 #Ci/ml, sp act, 56.6 mCi/mmol), and 50 mM Tris or 50 mM sodium acetate (pH 5.0), 150 mM NaC1, and 10 raM Ca 2+ (pH 7.4), with or without 6 mM Mg 2+ . After incubation for 30 rain at 37~ the reaction was stopped by the addition of 250 #1 CHCI~/CH3OH/CH3 COOH (4:2:1). Phospholipids were extracted, TIE was performed as described above and [14C]SM hydrolysis was quantitated by autoradiography and liquid scintillation. SMase activation was expressed as picomoles of SM hydrolyzed/10* cells.
Ceramide Mass Measurement (Diacylglycerot Kinase Assay). After stimulation, lipids were extracted and then incubated with Escherichia coli diacylglycerol kinase (21) . Geramide phosphate was then isolated by TIE using CHCI3/CH3OH/CH3COOH (65/15/5, vol/vol/vol) as solvent. Authentic ceramide-l-phosphate was identified by autoradiography at Kf 0.25. Quantitative results for ceramide production are expressed as pmohs of ceramide-l-phosphate/ 10' calls. different time points and analyzed by TIC. Fig. 2 A shows that cross-linking of CD95 in U937 cells resulted in significant hydrolysis of SM, which reached maximal levels by 5 rain, and was completed within 30 rain. Comparable peak levels of SM hydrolysis were observed by treating U937 cells for 5 rain with 100 ng/ml TNF-o~, used as positive control (Fig.  2 B) . Significant levels of SM hydrolysis were also observed 5 min after CD95 cross-linking in HUT78 and Jurkat cell lines (Fig. 2 B) , indicating that CD95-induced SM turnover was not restricted to U937 cells. Finally, remarkable SM hydrolysis was induced by anti-CD95 mAb DX2 in L1210-Fas calls (Fig. 2 B) , further indicating that expression of CD95 is sufficient to enable functional coupling with a SMase. SM hydrolysis was paralleled by generation of ceramide, as detected by TLC analysis of phospholipids extracted from DX2-stimulated U937 cells and subjected to diacylglycerol kinase assay (Fig. 3 A) . Ceramide accumulation peaked at 10 rain after CD95 cross-linking (Fig. 3 B) . Sphingosine for- with control mAb for 12 h were <2% (Fig. 1, A and B) . Kinetic analysis showed that a significant fraction of cells was undergoing apoptosis within 6 h from CD95 stimulation, and that almost all nuclei were hypodiploid by 24 h (Fig.  1 D) . Very similar results were obtained with P815 cells transfected with human CD95 (data not shown). These data indicated that the DX2 mAb recognized a functional epitope of the CD95 antigen.
Results

DX2 Is a New Functional Anti-CD95 mAt~
SM Breakdown is Induced by CD95 Cross-linking.
Crosslinking of TNFR-1 by TNF-cr in promyelocytic U937 calls results in SM hydrolysis and ceramide production (14) . The activation of SM turnover has been suggested to play an important role in initiating the biochemical pathway leading to active cell death, since synthetic ceramide analog C2-ceramide has been shown to be directly responsible for apoptosis induction in U937 cells (15) . As U937 cells express CD95 and are susceptible to CD95-mediated apoptosis induction (3), we investigated whether cross-linking of CD95 could induce SM breakdown in U937 cells. U937 cells were labeled with [/N/'-methyl-14C] choline for 48 h and stimulated with 1 #g/ml anti-CD95 mAb DX2, together with 1/~g/ml GuM to maximize cross-linking, since molecular cross-linking has been shown to be critical for CD95-mediated apoptosis induction (22) . Cellular phospholipids were then extracted at mation was observed, (band migrating at lower Kf in TLC), possibly due to rapid in vitro ceramide catabolism by ceramidases. The above results suggested that cross-linking of CD95 could transiently activate a cellular SMase to hydrolyse SM and generate ceramide. CD95 Cross-linking Activates an Acidic SMase. SMases represent a family of widely distributed type-C phospholipases. Although all SMases hydrolyse SM to generate ceramide and phosphorylcholine, ~hey are heterogeneous in activation requirements and cdlular localization (23) . Neutral SMases operate preferentially outside or at the plasma membrane, with a pH optimum of 7.4, and require Mg 2+, whereas acidic SMase are localized intracellularly and in lysosomes, have a pH optimum of 5.0, are Mg2+-independent and require 1,2-diacylglycerol for activation (24, 25) . It was of interest to characterize the SMase species involved in CD95 signaling. CD95-activated SMase activity was therefore evaluated in vitro on purified substrate, under different pH conditions. U937 cells were stimulated for 5 rain with 1/~g/ml anti-CD95 mAb DX2 and 1 #g/m1 GaM, and cell extracts were then incubated with labeled SM vesicles using pH 5.0 or 7.4 reaction buffers. As shown in Fig. 4 , optimal SMase activity was detected at pH 5.0, whereas at pH 7.4 enzymatic activity was minimal. Addition of 6 mM Mg 2+ to the reaction buffers did not result in any change in CD95-triggered SMase activity (data not shown). Cell extracts from TNF-ot-stimulated U937 cells, used as positive control, also contained acidic SMase activity, as reported (14) . These data indicated that CD95 cross-linking was activating an acidic SMase. Ceramide Mediates Apoptosis in CD95-sensitive Cell Lines. To further investigate the role of ceramide in CD95-induced cell death, we tested whether cell lines which were shown to generate ceramide upon CD95 cross-linking, were in fact induced to undergo apoptosis by exogenous ceramide. U937 cells, as already described (15), but also Jurkat, HUT78, and CD95-transfected L1210 cells, rapidly underwent massive apoptosis upon exposure to cell-permeant synthetic C2-ceramide. By contrast, cell-permeant structural analog C2-dihydroceramide was totally ineffective (Fig. 5) . These data strongly suggest that CD95-mediated ceramide generation is responsible for apoptosis induction in CD95-sensitive cells.
Concluding Remarks. Different cytokine receptors, including those for TNF-ot, IFN-3,, and IL-lfl, have been shown to trigger SM turnover, as part of their signaling capabilities, upon ligand binding (12, 13, 26) . SM hydrolysis with ceramide production is emerging as a major receptor-operated cell activation pathway (27) , highly conserved along evolution (28) and possibly implicated in multiple gene regulatory events, leading to as diverse outcomes as growth inhibition and cell differentiation (29, 30) or cellular proliferation (31) . Ceramides, in fact, can activate at least two distinct Ser/Thr kinases (32), one of which was identified as the 42-kD mitogen-activated protein kinase (33) , and a cytosolic Ser/Thr protein phosphatase 2A (termed ceramide-activated protein phosphatase or CAPP) (34) . The effects of C2-ceramide on apoptosis induction of U937 cells (15) , and the identification of a "death domain" common to CD95 and TNFR-1 (8, 9) , suggest the possibility that the SM pathway could mediate apoptotic signaling through CD95.
CD95-generated early signaling has remained elusive so far, as no early enzymatic activity or intracellular [Ca2+]i elevations, after CD95 cross-linking, have been reported. The data presented here provide the first attempt to characterize the signaling pathway originated at the CD95 receptor. They demonstrate that cross-linking of CD95 activates an acidic SMase in U937 cells and suggested that released ceramide could be involved in mediating CD95-dependent apoptosis. Although ceramides are likely candidates as mediators of CD95-dependent apoptosis, and CD95 triggers SM breakdown in all CD95 + call lines tested, a marked heterogeneity in susceptibility to CD95-mediated apoptosis induction among the different cell lines or among fleshly isolated cells has been observed (5 and our unpublished data). This suggests a complex and possibly call-specific regulation of the CD95-dependent SMase pathway, which will require further investigation.
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